RxSight, Inc. (RXST)

NASDAQ: RXST · IEX Real-Time Price · USD
11.12
0.10 (0.91%)
At close: Jan 14, 2022 4:00 PM
10.93
-0.19 (-1.71%)
After-hours:Jan 14, 2022 6:59 PM EST
Market Cap304.18M
Revenue (ttm)19.08M
Net Income (ttm)2.24M
Shares Out27.35M
EPS (ttm)-2.23
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume70,887
Open11.02
Previous Close11.02
Day's Range10.80 - 11.53
52-Week Range8.80 - 19.67
Betan/a
AnalystsStrong Buy
Price Target20.50 (+84.4%)
Earnings DateNov 10, 2021

About RXST

RxSight is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. Our proprietary RxSight Light Adjustable Lens system (“RxSight system”), comprised of our RxSight Light Adjustable Lens (“LAL”), RxSight Light Delivery Device (“LDD”) and accessories, is the first and only commercially available intraocular lens (“IOL”) technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. With the RxSight system, the surgeon per...

IndustryMedical Devices
IPO DateJul 30, 2021
CEORon Kurtz, M.D.
Employees171
Stock ExchangeNASDAQ
Ticker SymbolRXST
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 4 analysts, the average rating for RxSight stock is "Strong Buy." The 12-month stock price forecast is 20.50, which is an increase of 84.35% from the latest price.

Price Target
$20.50
(84.35% upside)
Analyst Consensus: Strong Buy

News

RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full Year 2021 Financial and Operational Results

ALISO VIEJO, Calif., Jan. 09, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today ...

6 days ago - GlobeNewsWire

RxSight, Inc. Appoints Dr. Tamara R. Fountain, M.D.

ALISO VIEJO, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today ...

1 week ago - GlobeNewsWire

RxSight to Present at the J.P. Morgan Healthcare Conference

ALISO VIEJO, Calif., Dec. 28, 2021 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST), an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today ...

2 weeks ago - GlobeNewsWire

RxSight to Participate in the Ophthalmology Day at BTIG

ALISO VIEJO, Calif., Nov. 18, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today ...

1 month ago - GlobeNewsWire

RxSight to Report Third Quarter 2021 Financial Results on November 10, 2021

ALISO VIEJO, Calif., Oct. 27, 2021 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company, today announced that it will report financial results for the third quarter of 2021 after the ...

2 months ago - GlobeNewsWire

RxSight Reports Second Quarter 2021 Financial Results

ALISO VIEJO, Calif., Sept. 09, 2021 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today reported finan...

4 months ago - GlobeNewsWire

RxSight Announces Updated Date for Reporting Second Quarter 2021 Financial Results on September 9, 2021

ALISO VIEJO, Calif., Sept. 01, 2021 (GLOBE NEWSWIRE) -- RxSight, Inc., (NASDAQ: RXST) an ophthalmic medical device company, today announced an updated date for reporting second quarter 2021 financial re...

4 months ago - GlobeNewsWire

RxSight to Participate in the Wells Fargo Healthcare Conference

ALISO VIEJO, Calif., Aug. 31, 2021 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST), an ophthalmic medical device company, today announced plans to participate in the upcoming virtual Wells Fargo Health...

4 months ago - GlobeNewsWire

RxSight to Report Second Quarter 2021 Financial Results on September 7, 2021

ALISO VIEJO, Calif., Aug. 24, 2021 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company, today announced that it will report financial results for the second quarter of 2021 after the...

4 months ago - GlobeNewsWire

Rani Therapeutics, RxSight: 2 Bullish Health Care Stock Picks From BofA

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI), an early stage platform technology company that promotes oral dosing with its RaniPill, and RxSight, Inc. (NASDAQ:RXST), an ophthalmology-focused MedTech ...

Other symbols:RANI
4 months ago - Benzinga

RxSight, Inc. Expands Commercial Leadership with Addition of Steve Everly as Vice-President of U.S. Sales

ALISO VIEJO, Calif., Aug. 17, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company, today announced that Steve Everly has joined the company as its Vice Presiden...

4 months ago - GlobeNewsWire

RxSight Announces Appointments to its Board of Directors

ALISO VIEJO, Calif., Aug. 10, 2021 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company, today announced the appointment of three new members to its Board of Directors effective as of...

5 months ago - GlobeNewsWire

RxSight, Inc. Announces Pricing of Initial Public Offering

ALISO VIEJO, Calif., July 29, 2021 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company, today announced the pricing of its initial public offering of 7,350,000 shares of common stock...

5 months ago - GlobeNewsWire